Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura

Bolton-Maggs, 2000, Idiopathic thrombocytopenic purpura, Arch Dis Child, 83, 220, 10.1136/adc.83.3.220 Medeiros, 1998, Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome, J Pediatr, 133, 334, 10.1016/S0022-3476(98)70265-3 Tarantino, 2000, Treatment options for chronic immune (idiopathic) thrombocytopenic purpura in children, Semin Hematol, 37, 35, 10.1016/S0037-1963(00)90117-3 George, 1996, Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for The American Society of Hematology, Blood, 88, 3, 10.1182/blood.V88.1.3.3 Mantadakis, 2000, Elective splenectomy in children with idiopathic thrombocytopenic purpura, J Pediatr Hematol/Oncol, 22, 148, 10.1097/00043426-200003000-00013 McLaughlin, 1998, Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program, J Clin Oncol, 16, 2825, 10.1200/JCO.1998.16.8.2825 Treon, 2000, The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders, Semin Oncol, 27, 79 Stasi, 2001, Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura, Blood, 98, 952, 10.1182/blood.V98.4.952 Faurschou, 2001, Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia, Eur J Haematol, 66, 408, 10.1034/j.1600-0609.2001.066006408.x Ratanatharathorn, 2000, Rituximab for refractory immune-mediated thrombocytopenia in chronic GVHD, Ann Intern Med, 133, 275, 10.7326/0003-4819-133-4-200008150-00011 Ahrens, 2001, Treatment of refractory autoimmune haemolytic anaemia with anti-cd20 (rituximab), Br J Haematol, 114, 242, 10.1046/j.1365-2141.2001.02873-4.x Levine, 1999, IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab, Neurology, 52, 1701, 10.1212/WNL.52.8.1701 Quartier, 2001, Treatment of childhood autoimmune haemolytic anaemia with rituximab, Lancet, 358, 1511, 10.1016/S0140-6736(01)06573-4 Hellmann SD, Grint PC. Important drug warning updated safety information. Genentech BioOncology and IDEC Pharmaceuticals Corporation (letter) May 8, 2001.